Researchers in medicine and biology are combining artificial intelligence with the study of interactions among microorganisms to improve early disease detection and better understand how diseases spread. Intelligent medical systems can analyze laboratory results alongside changes in a patient’s vital signs, helping clinical teams identify changes that warrant follow-up.
In biological control research, scientists study how beneficial microorganisms, including certain bacteria and fungi, can limit the growth of specific pathogens. By using artificial intelligence to analyze experimental data, researchers can compare the effects of these microorganisms under different conditions and identify findings that merit further investigation.
One clinical application involves analyzing the results of antibiotic susceptibility tests. By comparing results from samples collected over time, infection control teams can detect the repeated emergence of strains resistant to a particular antibiotic within a healthcare facility. This information can guide surveillance efforts and help physicians select treatment in light of each patient’s test results and clinical condition.
Collaboration between specialists in intelligent medical systems and microbiologists allows laboratory data to serve two complementary purposes. The data can inform decisions about individual patient care and reveal shifts in infection patterns that may be difficult to detect when cases are examined in isolation.
Al-Mustaqbal University — The Number One University in Iraq.